Dr. Reddy's Laboratories Ltd., of Hyderabad, India, said its wholly owned subsidiary Promius Pharma LLC, licensed the development, manufacturing, and commercialization rights to DFD-06, a topical steroid being developed for moderate to severe plaque psoriasis, to Encore Dermatology Inc., of Malvern, Pa. Promius is eligible to receive undisclosed pre- and post- commercialization milestone payments of up to $32.5 million and will receive fixed royalty payments on net sales.